Disclosure: Any research report published by Kalkine New Zealand Limited with respect to Tesla, Inc. will contain a disclosure in the report: "Kalkine New Zealand Limited's (Kalkine) director Kunal Sawhney owns shares of Tesla, Inc. since March 2024. Kalkine has recommended Tesla, Inc. in its report as general advice only (under FSP Number FSP691351). The advice given by Kalkine is provided for general informational purposes and should not be considered as personalized investment advice. Investors should conduct their own research and seek professional advice before making any investment decisions."

This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.